Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lisdexamfetamine Dimesylate in Chronic Fatigue Syndrome
NCT01071044Phase 4Completed
- Sponsor
- Rochester Center for Behavioral Medicine
- Start
- Nov 2009
- Primary completion
- Mar 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of lisdexamfetamine in myalgic encephalomyelitis chronic fatigue syndrome (ME/CFS), cognitive impairment, sponsored by Rochester Center for Behavioral Medicine. Started Nov 2009; status: completed.
02
Drugs
lisdexamfetamine
03
Conditions
myalgic encephalomyelitis chronic fatigue syndrome (ME/CFS)cognitive impairment
Beyond the preview
Go deeper on NCT01071044.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01071044.